πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 6 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9320793

Method for treating a disease associated with soluble, oligomeric species of amyloid beta

Acumen Pharmaceuticals, Inc. Β· Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9217024

ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

Acumen Pharmaceuticals, Inc. Β· Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9006283

Methods of modifying amyloid Ξ² oligomers using non-peptidic compounds

Acumen Pharmaceuticals, Inc. Β· Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962677

Methods of restoring cognitive ability using non-peptidic compounds

Acumen Pharmaceuticals, Inc. Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507206

Monoclonal antibodies that target pathological assemblies of amyloid Ξ² (Abeta)

Acumen Pharmaceuticals, Inc. Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964359

Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptak

Acumen Pharmaceuticals, Inc. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted